IP Library Granted Patent US 9,220,895
Granted Patent B2
US 9,220,895 · App. 14/247,930 · Granted Dec 29, 2015

Noninvasive or percutaneous nerve stimulation

Inventors: Bradford Siff (Westport, CA); Kenneth M. Peters (Royal Oak, CA)
Assignees: Biowave Corporation; William Beaumont Hospital
A61N1/36021A61N1/0456A61N1/36007A61N1/36014A61N1/0502A61N1/36003A61N1/36017
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,220,895
App. No.
14/247,930
Granted
Dec 29, 2015
Kind
B2
Abstract

A system and method of stimulating a nerve of a patient is provided. A electro-therapy device is used that includes a signal generator and two electrodes. The first electrode is positioned on an epidermis of the patient over the nerve to be stimulated. The second electrode is positioned on an epidermis of the patient at a second location. A The electro-therapy device is configured to alternately deliver to a first and second electrode a summation of first and second signals which result in a therapeutic signal encompassing the nerve of the patient. The intensity of the first and second signal is adjusted over time.

Claims (50)

1. A method of stimulating a nerve of a patient, comprising:

providing an electro-therapy device comprising:

a signal generator configured to produce first and second signals; and

a first and a second electrode;

positioning the first electrode on an epidermis of the patient over the nerve to be stimulated;

positioning the second electrode on an epidermis of the patient at a second location;

alternating the delivery of a summation of the first and second signals to the first electrode and the second electrode, wherein the first and second signals penetrate through the epidermis into deeper tissue;

forming, from the first and second signals, a therapeutic electrical field in the deeper tissue encompassing the nerve of the patient within a volume of tissue surrounding and beneath each respective first and second electrode; and

adjusting an intensity of the first and second signal over time.

2. The method of claim 1 , wherein the adjustment of the intensity of the first and second signal slowly increases to improve stimulation.

3. The method of claim 2 , wherein the adjustment of the intensity is in response to an interactive comfort setting by the patient.

4. The method of claim 1 , further comprising halting the application of the first and second signals after a predetermined time.

5. The method of claim 4 , wherein the predetermined time is 20 to 30 minutes.

6. The method of claim 1 , wherein the second location is on an epidermis of the patient at one of:

(1) over a second nerve to be stimulated;

(2) over a source of a pain;

(3) within a predetermined radius of the nerve to be stimulated; or

(4) over a bony prominence within a predetermined radius with respect to the nerve to be stimulated.

7. The method of claim 1 , wherein:

the nerve is a sacral nerve;

the first and second electrodes are non-invasive electrodes;

the first and second electrodes are of equal area such that the density of the electrical field is the same under the first and second electrodes; and

an active electrical field forms in an equal hemisphere beneath each electrode.

8. The method of claim 7 , wherein a diameter of the hemisphere is larger than a diameter of each electrode.

9. The method of claim 7 , wherein the first and second electrodes are placed adjacent and within a predetermined radius of each other to treat multiple branches of the nerve.

10. The method of claim 7 , wherein the nerve stimulation is performed by the patient without a doctor supervision and part of a therapy to at least one of (i) reduce pelvic floor pain, and (ii) improve range of motion of the patient.

11. The method of claim 1 , wherein:

the nerve is a tibial nerve;

the first and second electrodes are non-invasive electrodes and are configured to each create an electrical field in a body of the patient;

the first electrode has a surface area that is smaller than a surface area of the second electrode such that the density of the electrical field is greater under the first electrode than the second electrode; and

a diameter of a hemisphere of an active electrical field beneath the first electrode is larger than a diameter of the first electrode.

12. The method of claim 11 , wherein the second electrode is positioned over a bony prominence on a body of the patient.

13. The method of claim 12 , wherein the second electrode is positioned within a predefined radius of the nerve.

14. The method of claim 12 , wherein the nerve stimulation is performed by the patient without a doctor supervision and is part of a therapy to cure symptoms of urinary or fecal incontinence and overactive bladder syndrome (OAB).

15. The method of claim 11 , wherein the nerve stimulation is performed by the patient without a doctor supervision and is part of a therapy to cure symptoms of urinary or fecal incontinence and overactive bladder syndrome (OAB).

16. The method of claim 1 , wherein:

the nerve is a sacral nerve;

the first and second electrodes are percutaneous electrodes and are configured to each create an electrical field in a body of the patient;

the first and second electrodes are of substantially similar surface area and shape;

a diameter of a hemisphere of an active electrical field beneath the first electrode is substantially similar to an active electrical field beneath the second electrode; and

the diameter of the hemisphere of each active electrical field is slightly larger than the diameter of each electrode.

17. The method of claim 16 , further comprising positioning the second electrode on a second sacral nerve of the patient.

18. The method of claim 1 , wherein:

the nerve is a tibial nerve;

the first electrode is a percutaneous electrode and the second electrode is a non-invasive electrode, the electrodes being configured to each create an electrical field in a body of the patient;

the first electrode has an impedance that is less than the impedance of the second electrode;

a diameter of a hemisphere of an active electrical field beneath the first electrode is larger than an active electrical field beneath the second electrode; and

the diameter of the hemisphere of each active electrical field is slightly larger than the diameter of each electrode.

19. The method of claim 18 , wherein the second electrode is positioned over a bony prominence on a body of the patient.

20. The method of claim 18 , wherein the second electrode is positioned within a predefined radius of the position of the first electrode.

Assignments (4)
SECURITY INTEREST Recorded Aug 3, 2022
From: BIOWAVE CORPORATION
To: CONNECTICUT INNOVATIONS, INCORPORATED
Reel/Frame 060709/0205 →
SECURITY INTEREST Recorded Jan 30, 2020
From: BIOWAVE CORPORATION
To: CONNECTICUT INNOVATIONS, INCORPORATED
Reel/Frame 051675/0225 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2015
From: SIFF, BRADFORD
To: BIOWAVE CORPORATION
Reel/Frame 036356/0334 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2015
From: PETERS, KENNETH M., M.D.
To: WILLIAM BEAUMONT HOSPITAL
Reel/Frame 036356/0665 →
Continuity (2)
Provisional Application 61809688 · Apr 8, 2013
Related Publication 20140303682A1 · Oct 9, 2014